Valuation : Gedeon Richter

Market Cap 2,338B 7.5B 6.45B 6.07B 5.54B 10.37B 708B 10.4B 71.71B 27.83B 363B 28.15B 27.53B 1,170B P/E 2026 *
9.39x
P/E 2027 * 8.08x
Enterprise Value 2,065B 6.62B 5.7B 5.36B 4.89B 9.16B 625B 9.18B 63.32B 24.57B 321B 24.85B 24.31B 1,033B EV / Sales 2026 *
2.16x
EV / Sales 2027 * 1.87x
Free-Float
72.87%
Yield 2026 *
4.61%
Yield 2027 * 5.25%
1 week-3.25%
Current month-1.16%
1 month+6.89%
3 months+5.31%
6 months+17.98%
Current year+37.41%
1 week 34.66
Extreme 34.66
36.9
1 month 33
Extreme 33
37.26
3 years 21.84
Extreme 21.84
37.26
Manager TitleAgeSince
Chief Executive Officer 47 31/10/2017
Director of Finance/CFO - 30/04/2025
Chief Operating Officer - 31/12/2018
Director TitleAgeSince
Chairman 78 31/12/2016
Chairman 90 29/02/2024
Director/Board Member 65 25/04/2012
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-3.15%+35.54%+52.83% 7.5B
-0.89%-1.09%+19.16%+67.77% 48.26B
-1.72%-1.15%+45.80%+117.34% 40.5B
-0.70%-2.70%-10.84%+11.79% 11.85B
-2.01%-5.96%+10.47%+76.64% 11.83B
+2.31%0.00%+26.67%+153.33% 9.36B
+0.08%-4.11%+24.83%+43.80% 7.5B
-1.67%-0.35%+41.04%-11.59% 7.37B
-0.89%-3.09%+18.78%+207.82% 7.28B
-0.16%-2.36%-46.14%+16.28% 5.19B
Average -0.63%-2.09%+16.53%+73.60% 16.57B
Weighted average by Cap. -0.95%-1.71%+23.48%+81.35%

Financials

2026 *2027 *
Net sales 957B 3.07B 2.64B 2.48B 2.27B 4.24B 290B 4.26B 29.35B 11.39B 149B 11.52B 11.27B 479B 1,026B 3.29B 2.83B 2.66B 2.43B 4.55B 311B 4.56B 31.47B 12.21B 159B 12.35B 12.08B 513B
Net income 255B 818M 703M 662M 605M 1.13B 77.19B 1.13B 7.82B 3.04B 39.6B 3.07B 3B 128B 290B 930M 800M 753M 688M 1.29B 87.79B 1.29B 8.9B 3.45B 45.04B 3.49B 3.42B 145B
Net Debt -274B -877M -755M -710M -649M -1.21B -82.82B -1.22B -8.39B -3.26B -42.49B -3.29B -3.22B -137B -422B -1.35B -1.16B -1.1B -1B -1.87B -128B -1.88B -12.95B -5.02B -65.56B -5.08B -4.97B -211B
Logo Gedeon Richter
Richter Gedeon Vegyeszeti Gyar Nyrt is a Hungary-based company engaged in the research, development, production and marketing and trade of pharmaceutical products. The Company’s business is structured into three segments: the Pharmaceuticals segment, which includes the companies that are involved in the Company’s core business, including research, development and production of pharmaceutical products; the Wholesale and retail segment covers distribution companies and pharmacies that are part of the sales network in various regional markets and, as such convey its products to consumers, and the Other segment presents all the other consolidated companies that provide marketing and sales support services. The Company’s subsidiaries include, among others, Gedeon Richter Romania SA, Gedeon Richter Polska Sp Z.o.o., and ZAO Gedeon Richter-RUS.
Employees
-
Date Price Change
04/09/26 €35.70 0.00%
03/09/26 €35.70 +2.06%
02/09/26 €34.98 -1.85%
01/09/26 €35.64 -1.33%
31/08/26 €36.12 -2.11%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
12,820.00HUF
Average target price
12,957.43HUF
Spread / Average Target
+1.07%

Quarterly revenue - Rate of surprise